Compound heterozygous RYR1 ‐ RM mouse model reveals disease pathomechanisms and muscle adaptations to promote postnatal survival
The FASEB Journal · 2024
DOI: 10.1096/fj.202401189r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Chen Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York, USA. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Muscle, Skeletal, Disease Models, Animal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: NIAMS NIH HHS, Friedreich's Ataxia Research Alliance (FARA), National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Pathogenic variants in the type I ryanodine receptor (RYR1) result in a wide range of muscle disorders referred to as RYR1‐related myopathies (RYR1‐RM). We developed the first RYR1‐RM mouse model resulting from co‐inheritance of two different RYR1 missense alleles ( Ryr1 TM/SC‐ΔL mice). Ryr1 TM/SC‐ΔL mice exhibit a severe, early onset myopathy characterized by decreased body/muscle mass, muscle weakness, hypotrophy, reduced RYR1 expression, and unexpectedly, incomplete postnatal lethality with a plateau survival of ~50% at 12 weeks of age. Ryr1 TM/SC‐ΔL mice display reduced respiratory function, locomotor activity, and in vivo muscle strength. Extensor digitorum longus muscles from Ryr1 TM/SC‐ΔL mice exhibit decreased cross‐sectional area of type IIb and type IIx fibers, as well as a reduction in number of type IIb fibers. Ex vivo functional analyses revealed reduced Ca 2+ release and specific force production during electrically‐evoked twitch stimulation. In spite of a ~threefold reduction in RYR1 expression in single muscle fibers from Ryr1 TM/SC‐ΔL mice at 4 weeks and 12 weeks of age, RYR1 Ca 2+ leak was not different from that of fibers from control mice at either age. Proteomic analyses revealed alterations in protein synthesis, folding, and degradation pathways in the muscle of 4‐ and 12‐week‐old Ryr1 TM/SC‐ΔL mice, while proteins involved in the extracellular matrix, dystrophin‐associated glycoprotein complex, and fatty acid metabolism were upregulated in Ryr1 TM/SC‐ΔL mice that survive to 12 weeks of age. These findings suggest that adaptations that optimize RYR1 expression/Ca 2+ leak balance, sarcolemmal stability, and fatty acid biosynthesis provide Ryr1 TM/SC‐ΔL mice with an increased survival advantage during postnatal development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York, USA.
- Department of Medicine, Cardiovascular Research Institute, University of Rochester, Rochester, New York, USA.
ORCID-Profile: Chen Liang, Miao He, Sara K Ture, Robert T Dirksen
Förderung
- NIAMS NIH HHS
- Friedreich's Ataxia Research Alliance (FARA)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Liang, C., Malik, S., He, M., Groom, L., Ture, S. K., O'Connor, T. N., Morrell, C. N., & Dirksen, R. T. (2024). Compound heterozygous RYR1 ‐ RM mouse model reveals disease pathomechanisms and muscle adaptations to promote postnatal survival. The FASEB Journal. https://doi.org/10.1096/fj.202401189r
Vancouver
Liang C, Malik S, He M, Groom L, Ture SK, O'Connor TN, et al. Compound heterozygous RYR1 ‐ RM mouse model reveals disease pathomechanisms and muscle adaptations to promote postnatal survival. The FASEB Journal. 2024. doi:10.1096/fj.202401189r
BibTeX
@article{Liang2024,
author = {Liang, Chen and Malik, Sundeep and He, Miao and Groom, Linda and Ture, Sara K and O'Connor, Thomas N and Morrell, Craig N and Dirksen, Robert T},
title = {Compound heterozygous RYR1 ‐ RM mouse model reveals disease pathomechanisms and muscle adaptations to promote postnatal survival},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202401189r}
}
EUVIMED